CCMI
TMDX icon

Creative Capital Management Investments’s Transmedics TMDX Stock Holding History

Creative Capital Management Investments’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133 Buy
+2
New +$169 ﹤0.01% 1420

Other funds holding TMDX

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
STAS
Strong Tower Advisory Services Minneapolis, Minnesota $558M AUM 13.89% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Creative Capital Management Investments's TMDX Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Transmedics (TMDX) in Q2 2026: 2 shares worth $133. The stake represents ﹤0.01% of the portfolio and ranks #1420 among its holdings.

75 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Creative Capital Management Investments held 2 shares of Transmedics worth $133 as of Q2 2026.
  • Transmedics was a new Creative Capital Management Investments position in Q2 2026.
  • Transmedics made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1420 holding.
  • 75 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.